Page 8 - IJB-2-2
P. 8

Advancing cancer research using bioprinting for tumor-on-a-chip platforms

            therapies  in  vitro.  Traditional  two-dimensional (2D)   2. Advantages of Bioprinting for Tumor-on-a-
            approaches to  cancer research  have left significant   chip Fabrication
            gaps in our understanding of the disease as well as our
            ability  to  develop  effective  treatments.  This is partly   2.1 Mimicking Tumor Heterogeneity
            due to the inability of 2D cancer models to recapitu-  To mimic the tumor microenvironment, 3D-printed
            late the microenvironment of a tumor which exists in   tissues must mimic various features of in vivo tumors,
            the human body. Past studies have demonstrated a   including  heterogeneous distribution of several dif-
            significant difference in cell behavior between 2D and   ferent cell types and biomolecules, in order to serve as
            3D  models, specifically  in  terms  of  protein  express-  a physiologically-relevant model for cancer research.
                                     [3]
               [2]
            ion   and gradient profiles , drug response [4,5] ,  as   With the bioprinting technology, cell-aggregate based
                               [6]
                                                         [8]
                                            [7]
            well as cell migration , morphology , proliferation    bioinks can contain multiple cell types [16]  such as can-
                       [7]
            and viability . Cell-cell and  cell-matrix  interactions   cer-associated fibroblasts, immune cells and  endo-
            are enhanced in 3D models compared to 2D, offering   thelial cells that create  vascular networks [17] . Bio-
            a more physiologically-relevant microenvironment.   printing has been used to fabricate  a  3D co-culture
            Bioprinting offers the ability to generate cancer mod-
            els  with  3D  complexity  in  a  high-throughput,  repro-  tumor model comprised of cancer and fibroblast cells
            ducible manner which better reflects tumor anatomy,   with a high degree of spatial control over the micro-
                                                                         [18]
            biology and function and will serve as a platform for   environment  .  It is also important to consider the
                                [9]
            further cancer research .                          heterogeneous distribution of biologically-relevant
               Integration  of  fabricated  tissues into  microfluidic   proteins  and growth factors in the tissue scaffold,
            devices has given rise to a new field of interest, called   which are essential to control cell signaling, prolifera-
                                                                               [19]
            “organs-on-a-chip,” adding a new level of complexity   tion, and migration  . For example, biomolecule gra-
                                                                                                    [20]
            in the ability to model living organs in vitro. Use of   dients which  may signal cancer metastasis    can  be
            microfluidic devices as a platform for tissue engineer-  recreated  using bioprinting techniques. In summary,
            ing offers several advantages over static culture [10,11] .   bioprinting provides a method to mimic the heteroge-
            Exposing tissues to continuous fluid flow over a pro-  neous tumor microenvironment  in  vitro  with  a  high
            longed time allows integration of dynamic mechanical   level of precision, throughput and reproducibility.
            cues into biomimetic  systems.  These cues,  such as   2.2 Modeling Tumor Vasculature
            shear stress, are crucial to accurately mimic the physi-
            ological microenvironment in in vitro systems. In par-  Tumor vasculature differs greatly from the vessels that
            ticular to tumor models, it has been shown that inters-  supply healthy tissue, specifically in the heterogeneity,
            titial fluid flow in and around the tissue generates   permeability, multi-directional blood flow, and irregu-
            shear  stress, which causes  cell  cycle  arrest  in tumor   lar distribution throughout the tumor [21] . These ab-
            cell lines [12] . It has also been shown that cancer cells   normalities can be mimicked by using 3D-printed
            migrate along the direction of fluid streamlines in 3D   vascular networks which can be further utilized to test
            scaffolds [13] , further highlighting the importance  of   and compare the  behavior  of healthy and abnormal
            mechanical cues to modulate molecular signals, gene   vasculature under different conditions and therapies.
            expression, and cell proliferation and migration. Mor-  In one study, 25, 45, and 120 micron channels were
            eover, due to the small dimensions of microfluidic   3D printed  based on micro-computed tomography
            channels, the flow in these devices is laminar, thus   (µCT) scans of rat capillaries [22] . This biomimetic chip
            affording the ability to generate complex and highly   was used to observe the differences in cancer cell mi-
            controllable fluid flow regimes. For example, this ca-  gration through vessels of different sizes.
            pability enables generation of sustainable gradients of   Understanding tumor vasculature is also crucial to
            chemicals and biomolecules to study cell response to   understanding drug delivery to tumors and developing
            chemotactic stimuli. Chemotaxis is known to be im-  effective chemotherapeutics.  The leaky and  poorly-
            portant for tumor cell homing, which plays an integral   organized blood vessels supplying tumors significantly
            role in cancer metastasis [14] . Lab-on-a-chip platforms   impact drug delivery [23] . This makes it difficult to test
            not only recreate a biomimetic microenvironment, but   drugs in alternative tissue models due to differences in
            also offer high throughput for systematic testing, such   drug permeability through normal vasculature com-
            as drug screening [15] .                           pared to leaky vessels. However, in future bioprinting

            4                           International Journal of Bioprinting (2016)–Volume 2, Issue 2
   3   4   5   6   7   8   9   10   11   12   13